TERMIUM® is the Government of Canada’s terminology and linguistic data bank. C12N15/ Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming. La présente invention concerne des compositions de microparticules, les microparticules étant constituées d’acides nucléiques et de cations non polymères et.

Author: Moogubar Mizilkree
Country: Samoa
Language: English (Spanish)
Genre: Finance
Published (Last): 20 March 2014
Pages: 297
PDF File Size: 1.26 Mb
ePub File Size: 19.36 Mb
ISBN: 260-4-88938-966-8
Downloads: 51330
Price: Free* [*Free Regsitration Required]
Uploader: Zurisar

EP2799548A1 – Acide nucléique antisens – Google Patents

CA CAC fr Efficient, high-throughput production of human proteins in bacteria. Variable-speed wind power system with improved energy capture via multilevel conversion. A1 Designated state s: Extended dicer substrate agents and methods for the specific inhibition of gene expression. Immobilizing and processing specimens on matrix materials for the identification of nucleic acid sequences.

Acode layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Procede servant a produire une preparation complexe contenant des acides nucleiques.

Apparatus and method for simplifying the processes in creating a sealed space on slides to conduct molecular biological reactions therein. US USB2 nnucleique Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery.

Amorces de diagnostic et procede de detection des sous-types h5 et h5n1 du virus de la grippe aviaire. Kind code of ref document: Antisense oligomers and methods for inducing immune tolerance and immunosuppression. CA CAA1 fr Oligonucleotide comprenant une inosine pour traiter une dystrophie musculaire de duchenne dmd.


A1 Designated state s: In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA—DNA carrying microparticles to dendritic cells. EP EPA2 fr Country of ref document: Kind code of ref nucleiqus CN CNB zh Methods for amplifying and detecting multiple polynucleotides on a solid phase support.

Recent advances in the stereocontrolled synthesis of antisense phosphorothioates. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations.

Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres.

Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.

EPA1 – Acide nucléique antisens – Google Patents

Dosages d’hybridation par la reaction en chaine de la polymerase specifiques a des retrovirus integres. Single stranded extended dicer substrate agents and methods for the specific inhibition of jucleique expression. Request for preliminary examination filed prior to expiration of 19th month from priority date pct application filed from Polymeres non charges bucleique base de morpholine ayant des liaisons chirales phosphoreuses entre les sous-unites.

AU Date of ref document: Oligonucleotide compositions and methods for the modulation of the expression of B7 protein. Microparticules biodegradables pour administration soutenue de medicaments therapeutiques. Secuencia oligoribonucleotidica homologa a una region del cdna que codifica para el receptor cd40 humano y oligoribonucleotidos duplex, vectores, composiciones farmaceuticas y usos correspondientes. Modulation de la reconnaissance d’exons dans le pre-arnm par interference avec la structure d’arn secondaire.


Oligonucleotide nucoeique comprising dna-like and rna-like nucleotides and uses thereof. Date of ref document: Retrograde transport of sirna and acde uses to treat neurologic disorders.

Country of ref document: Method for isolating biomolecules from a biological sample with linear polymers. De Geest et al.

Structure secondaire d’un acide nucléique — Wikipédia

Test de malignite test de depistage du cancer par la reaction en chaine de la polymerase. Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents. Solution hybridization of nucleic acids with antisense probes having modified backbones.


Deciphering human protein families: In situ hybridization to detect specific nucleic acid sequences in eucaryotic samples. Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof. Procede ameliore de detection et d’identification de micro-organismes causes d’infections. In situ forming implants—an attractive formulation principle for parenteral depot formulations. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid siNA.

Kind code of ref document: